Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy.

Authors :: Mitsuhashi K
Ishiyama M
Imai Y
Shiseki M
Mori N
Teramura M
Seshimo A
Motoji T
Source :: British journal of haematology [Br J Haematol] 2012 Sep; Vol. 158 (6), pp. 798-800. Date of Electronic Publication: 2012 Jul 03.
Publication Year :: 2012

Subjects :: Aged
Antibodies, Monoclonal, Murine-Derived adverse effects
Antibodies, Monoclonal, Murine-Derived therapeutic use
Blood Platelets immunology
Combined Modality Therapy
Drug Resistance
Drug Therapy, Combination
Humans
Immunoglobulin G immunology
Immunoglobulins, Intravenous administration & dosage
Immunosuppressive Agents therapeutic use
Male
Platelet Count
Preoperative Care
Purpura, Thrombocytopenic, Idiopathic drug therapy
Purpura, Thrombocytopenic, Idiopathic surgery
Receptors, Fc administration & dosage
Recombinant Fusion Proteins administration & dosage
Rituximab
Thrombopoietin administration & dosage
Immunoglobulins, Intravenous therapeutic use
Purpura, Thrombocytopenic, Idiopathic therapy
Receptors, Fc therapeutic use
Receptors, Thrombopoietin agonists
Recombinant Fusion Proteins therapeutic use
Splenectomy
Thrombopoietin therapeutic use

Full Text Access

Tools